Analysis of Clinicopathological Characteristics and Prognosis of Carcinosarcoma of the Breast

Table 2

Univariate and multivariate analysis of patients’ disease-free survival.

Factors	DFS
	Univariate		Multivariate
	value	HR (95% CI)	value	HR (95% CI)
Age	0.120	2.015 (0.832–4.878)
Menopausal status	0.151	1.914 (0.790–4.638)
Tumor size	0.023	3.362 (1.187–9.524)
T stage at diagnosis	0.097	0.363 (0.110–1.200)
N stage at diagnosis	0.043	3.663 (1.039–12.91)
Therapeutic method	0.041	0.385 (0.154–0.963)
TI (D)	0.028	3.164 (1.130–8.862)	0.005	3.752 (1.499–9.392)
Adjuvant chemotherapy	0.014	0.324 (0.132–0.800)	0.004	4.396 (1.587–12.173)

HR: hazard ratio; CI: confidence interval; TI (D): time interval between first discomfort and first consultation (days).